Establishment of (68)Ga-DOTA-Based Pretargeted Radioimmunodiagnosis.

Veach DR, Burnes Vargas D, Islam B, Lee SG, Gajecki L, Vaughn BA, Yang G, Kalidindi TM, Pillarsetty NVK, Salehi N, Jaswal AP, Saha S, Le Roux AB, Xu H, Guo HF, Ouerfelli O, Cheung NV, Krebs S, Larson SM, Cheal SM

Open source

DOI
10.1021/acs.molpharmaceut.5c01766
Published
2026 Jun 1
Container
Molecular pharmaceutics
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1021/acs.molpharmaceut.5c01766,
  title = {Establishment of (68)Ga-DOTA-Based Pretargeted Radioimmunodiagnosis.},
  author = {Veach DR and Burnes Vargas D and Islam B and Lee SG and Gajecki L and Vaughn BA and Yang G and Kalidindi TM and Pillarsetty NVK and Salehi N and Jaswal AP and Saha S and Le Roux AB and Xu H and Guo HF and Ouerfelli O and Cheung NV and Krebs S and Larson SM and Cheal SM},
  year = {2026},
  journal = {Molecular pharmaceutics},
  doi = {10.1021/acs.molpharmaceut.5c01766},
  url = {https://doi.org/10.1021/acs.molpharmaceut.5c01766}
}

RIS

TY  - JOUR
TI  - Establishment of (68)Ga-DOTA-Based Pretargeted Radioimmunodiagnosis.
AU  - Veach DR
AU  - Burnes Vargas D
AU  - Islam B
AU  - Lee SG
AU  - Gajecki L
AU  - Vaughn BA
AU  - Yang G
AU  - Kalidindi TM
AU  - Pillarsetty NVK
AU  - Salehi N
AU  - Jaswal AP
AU  - Saha S
AU  - Le Roux AB
AU  - Xu H
AU  - Guo HF
AU  - Ouerfelli O
AU  - Cheung NV
AU  - Krebs S
AU  - Larson SM
AU  - Cheal SM
PY  - 2026
JO  - Molecular pharmaceutics
DO  - 10.1021/acs.molpharmaceut.5c01766
UR  - https://doi.org/10.1021/acs.molpharmaceut.5c01766
ER  - 

APA

DR, V., D, B. V., B, I., SG, L., L, G., BA, V., G, Y., TM, K., NVK, P., N, S., AP, J., S, S., AB, L. R., H, X., HF, G., O, O., NV, C., S, K., SM, L., & SM, C. (2026). Establishment of (68)Ga-DOTA-Based Pretargeted Radioimmunodiagnosis.. Molecular pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.5c01766

Source records